5Alcorta I,Pereira A,Ordinas A,el al.Clitical and laboratory factors associated with transfusion refractoriness a case-control study[J].Br J Haematol,1996,93(1):220-224.
二级参考文献6
1[1]Williamson LM,Wimperis JZ,Williamson P.Bedside filtration of blood products in the prevention of HLA-alloimmunization [J].Blood,1999;84:3078-3079.
2[2]Sichter SJ.The trail to reduce alloimmunization to prevent alloimmuniza [J].N Engl J Med,1997;337:1861.
3[3]Chun HY.Prospects For the platelet transfusion [J].Clin Blood,1998;39(2):78-79.
4[4]Kevin D,Heckman,George J.Randomized Study of proghylatic transfusion threshold during induction therapy for adult platelet acute Leakemia:1000/μl vs 2000/μl [J].J Clin Oncol,1997;15(3):1143-1149.
5T. J. Legler,I. Fischer,J. Dittmann,G. Simson,R. Lynen,A. Humpe,J. Riggert,E. Schleyer,W. Kern,W. Hiddemann,M. K?hler. Frequency and causes of refractoriness in multiply transfused patients[J] 1997,Annals of Hematology(4):185～189
6J. M. Heal,J. M. Rowe,N. Blumberg. ABO and platelet transfusion revisited[J] 1993,Annals of Hematology(6):309～314
6Slichter SJ,Davis K,Enright H. Factors affecting posttransfusion platelet increments,Platelet,refractoriness,and platelet transfusion intervals in thrombocytopenic patients[J].Blood,2005,(12):4106-4114.
7Bladuini CL,Salvaneschi L,Klersy C. Factors influencing ost transfusional platelet increment in pediatric patients given hematopiuetic stem cell transplantation[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2001,(12):1885-1891.
8Heuer L,Blumenberg D. Management of bleeding in a multitransfused patient with positive HLA class I alloantibodies and thromb ocytopenia associated with platelet dysfunction refractory to transfusion of cross matched platelets[J].Blood Coagul Fibrinolysid,2005.287-290.
9lillickS B,WinN,Marsh J C. Pilot study of HLA alloimmunization after transfusion with pre storage leucodeted blood products in aplastic anaemia[J].British Journal of Haematology,1997,(03):667-684.
